Date Action Amount Person Type
May 03, 2024 Buy 747 Levy Richard S Class A Common Share
May 03, 2024 Buy 747 Levy Richard S Restricted Share Units
May 03, 2024 Sell 747 Levy Richard S Restricted Share Units
Apr 26, 2024 Buy 991 Ragosa Mark Class A Common Share
Apr 26, 2024 Sell 509 Ragosa Mark Class A Common Share
Apr 26, 2024 Buy 991 Ragosa Mark Restricted Share Unit
Apr 08, 2024 Buy 9 992 Patel Sanj K Class A Common Share
Apr 08, 2024 Sell 4 075 Patel Sanj K Class A Common Share
Apr 08, 2024 Sell 9 992 Patel Sanj K Restricted Share Unit
Apr 08, 2024 Buy 2 497 Paolini John F. Class A Common Share
Apr 08, 2024 Sell 733 Paolini John F. Class A Common Share
Apr 08, 2024 Sell 2 497 Paolini John F. Restricted Share Unit
Apr 08, 2024 Buy 2 694 Ragosa Mark Class A Common Share
Apr 08, 2024 Sell 791 Ragosa Mark Class A Common Share
Apr 08, 2024 Sell 2 694 Ragosa Mark Restricted Share Unit
Apr 08, 2024 Buy 2 477 Moat Ross Class A Common Share
Apr 08, 2024 Sell 1 353 Moat Ross Class A Common Share
Apr 08, 2024 Sell 2 477 Moat Ross Restricted Share Unit
Apr 08, 2024 Buy 3 932 Megna Michael R Class A Common Share
Apr 08, 2024 Sell 1 666 Megna Michael R Class A Common Share
Apr 08, 2024 Sell 3 932 Megna Michael R Restricted Share Unit
Apr 08, 2024 Buy 2 726 Tessari Eben Class A Common Share
Apr 08, 2024 Sell 801 Tessari Eben Class A Common Share
Apr 08, 2024 Sell 2 726 Tessari Eben Restricted Share Unit
Apr 04, 2024 Buy 129 750 Patel Sanj K Share Option
Apr 04, 2024 Buy 24 950 Patel Sanj K Restricted Share Unit
Apr 04, 2024 Buy 20 000 Patel Sanj K Performance Share Unit
Apr 04, 2024 Buy 36 350 Paolini John F. Share Option
Apr 04, 2024 Buy 7 000 Paolini John F. Restricted Share Unit
Apr 04, 2024 Buy 5 600 Paolini John F. Performance Share Unit
Apr 04, 2024 Buy 33 150 Ragosa Mark Share Option
Apr 04, 2024 Buy 6 365 Ragosa Mark Restricted Share Unit
Apr 04, 2024 Buy 5 092 Ragosa Mark Performance Share Unit
Apr 04, 2024 Buy 36 100 Moat Ross Share Option
Apr 04, 2024 Buy 6 962 Moat Ross Restricted Share Unit
Apr 04, 2024 Buy 5 569 Moat Ross Performance Share Unit
Apr 04, 2024 Buy 18 900 Megna Michael R Share Option
Apr 04, 2024 Buy 9 450 Megna Michael R Restricted Share Unit
Apr 04, 2024 Buy 36 300 Tessari Eben Share Option
Apr 04, 2024 Buy 6 981 Tessari Eben Restricted Share Unit
Apr 04, 2024 Buy 5 585 Tessari Eben Performance Share Unit
Apr 01, 2024 Buy 1 750 Ragosa Mark Class A Common Share
Apr 01, 2024 Sell 514 Ragosa Mark Class A Common Share
Apr 01, 2024 Sell 1 750 Ragosa Mark Restricted Share Unit
Apr 01, 2024 Buy 1 773 Tessari Eben Class A Common Share
Apr 01, 2024 Sell 521 Tessari Eben Class A Common Share
Apr 01, 2024 Sell 1 773 Tessari Eben Restricted Share Unit
Apr 01, 2024 Buy 6 482 Patel Sanj K Class A Common Share
Apr 01, 2024 Sell 1 903 Patel Sanj K Class A Common Share
Apr 01, 2024 Sell 6 482 Patel Sanj K Restricted Share Unit
Apr 01, 2024 Buy 2 558 Megna Michael R Class A Common Share
Apr 01, 2024 Sell 1 084 Megna Michael R Class A Common Share
Apr 01, 2024 Sell 2 558 Megna Michael R Restricted Share Unit
Apr 01, 2024 Buy 1 612 Moat Ross Class A Common Share
Apr 01, 2024 Sell 880 Moat Ross Class A Common Share
Apr 01, 2024 Sell 1 612 Moat Ross Restricted Share Unit
Apr 01, 2024 Buy 1 624 Paolini John F. Class A Common Share
Apr 01, 2024 Sell 477 Paolini John F. Class A Common Share
Apr 01, 2024 Sell 1 624 Paolini John F. Restricted Share Unit
Mar 07, 2024 Sell 65 012 Patel Sanj K Class A Common Share
Mar 06, 2024 Sell 5 582 Patel Sanj K Class A Common Share
Mar 04, 2024 Sell 9 406 Patel Sanj K Class A Common Share
Mar 04, 2024 Sell 3 336 Patel Sanj K Class A Common Share
Mar 01, 2024 Buy 656 Tessari Eben Class A Common Share
Mar 01, 2024 Sell 1 189 Tessari Eben Class A Common Share
Mar 01, 2024 Sell 656 Tessari Eben Share Option
Mar 01, 2024 Sell 18 844 Paolini John F. Share Option
Mar 01, 2024 Buy 18 844 Paolini John F. Class A Common Share
Mar 01, 2024 Sell 18 844 Paolini John F. Class A Common Share
Mar 01, 2024 Buy 4 014 Megna Michael R Class A Common Share
Mar 01, 2024 Buy 5 645 Megna Michael R Class A Common Share
Mar 01, 2024 Sell 9 659 Megna Michael R Class A Common Share
Mar 01, 2024 Sell 5 645 Megna Michael R Share Option
Mar 01, 2024 Sell 4 014 Megna Michael R Share Option
Feb 28, 2024 Buy 5 126 Megna Michael R Class A Common Share
Feb 28, 2024 Sell 5 126 Megna Michael R Class A Common Share
Feb 28, 2024 Sell 5 126 Megna Michael R Share Option
Feb 27, 2024 Sell 10 156 Paolini John F. Share Option
Feb 27, 2024 Buy 10 156 Paolini John F. Class A Common Share
Feb 27, 2024 Sell 10 156 Paolini John F. Class A Common Share
Jan 15, 2024 Buy 583 Megna Michael R Class A Common Share
Jan 03, 2024 Buy 12 000 Ragosa Mark Class A Common Share
Jan 03, 2024 Sell 12 000 Ragosa Mark Class A Common Share
Jan 03, 2024 Sell 12 000 Ragosa Mark Share Option
Jan 02, 2024 Buy 16 670 Megna Michael R Class A Common Share
Jan 02, 2024 Sell 16 670 Megna Michael R Class A Common Share
Jan 02, 2024 Sell 16 670 Megna Michael R Share Option
Dec 19, 2023 Buy 9 316 Megna Michael R Class A Common Share
Dec 19, 2023 Sell 9 316 Megna Michael R Share Option
Dec 19, 2023 Sell 9 316 Megna Michael R Class A Common Share
Dec 07, 2023 Sell 28 600 Paolini John F. Share Option
Dec 07, 2023 Buy 28 600 Paolini John F. Class A Common Share
Dec 07, 2023 Sell 7 380 Paolini John F. Class A Common Share
Dec 07, 2023 Sell 13 017 Paolini John F. Class A Common Share
Dec 07, 2023 Sell 6 702 Paolini John F. Class A Common Share
Dec 07, 2023 Sell 1 501 Paolini John F. Class A Common Share
Nov 03, 2023 Buy 2 777 Levy Richard S Class A Common Share
Nov 03, 2023 Buy 2 777 Levy Richard S Restricted Share Units
Nov 03, 2023 Sell 2 777 Levy Richard S Restricted Share Units
Oct 04, 2023 Buy 175 Megna Michael R Class A Common Share
INSIDER POWER
22.655
Last 100 transactions
Buy: 555 036 | Sell: 364 871 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 22.655.

In total, the insiders bought 555 036 and sold 364 871 KNSA shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Kiniksa Pharmaceuticals Ltd. Class A

Kiniksa Pharmaceuticals Ltd. Class A Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Mavrilimumab, a monoclo... KNSA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT